-
1
-
-
84857068554
-
What's wrong with chemoprevention of prostate cancer?
-
Justman, S. 2011. What's wrong with chemoprevention of prostate cancer?. American Journal of Bioethics, 11(12): 21-25.
-
(2011)
American Journal of Bioethics
, vol.11
, Issue.12
, pp. 21-25
-
-
Justman, S.1
-
2
-
-
63049099067
-
Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 clinical practice guideline
-
Kramer, B. S., Hagerty, K. L.Justman, S. 2009. Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 clinical practice guideline. Journal of Clinical Oncology, 27: 1502-1516.
-
(2009)
Journal of Clinical Oncology
, vol.27
, pp. 1502-1516
-
-
Kramer, B.S.1
Hagerty, K.L.2
Justman, S.3
-
3
-
-
61749093320
-
Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: Implications for prostate cancer detection and chemoprevention
-
Lucia, M. S., Darke, A. K.Goodman, P. J. 2008. Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: Implications for prostate cancer detection and chemoprevention. Cancer Prevention Research (Philadelphia), 1: 167-173.
-
(2008)
Cancer Prevention Research (Philadelphia)
, vol.1
, pp. 167-173
-
-
Lucia, M.S.1
Darke, A.K.2
Goodman, P.J.3
-
4
-
-
34748863567
-
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial
-
Lucia, M. S., Epstein, J. I.Goodman, P. J. 2007. Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial. Journal of the National Cancer Institute, 99: 1375-1383.
-
(2007)
Journal of the National Cancer Institute
, vol.99
, pp. 1375-1383
-
-
Lucia, M.S.1
Epstein, J.I.2
Goodman, P.J.3
-
5
-
-
79960210525
-
The risks and benefits of 5alpha-reductase inhibitors for prostate-cancer prevention
-
Theoret, M. R., Ning, Y. M., Zhang, J. J., Justice, R., Keegan, P. and Pazdur, R. 2011. The risks and benefits of 5alpha-reductase inhibitors for prostate-cancer prevention. New England Journal of Medicine, 365: 97-99.
-
(2011)
New England Journal of Medicine
, vol.365
, pp. 97-99
-
-
Theoret, M.R.1
Ning, Y.M.2
Zhang, J.J.3
Justice, R.4
Keegan, P.5
Pazdur, R.6
-
6
-
-
33747407318
-
Effect of finasteride on the sensitivity of PSA for detecting prostate cancer
-
Thompson, I. M., Chi, C.Ankerst, D. P. 2006. Effect of finasteride on the sensitivity of PSA for detecting prostate cancer. Journal of the National Cancer Institute, 98: 1128-1133.
-
(2006)
Journal of the National Cancer Institute
, vol.98
, pp. 1128-1133
-
-
Thompson, I.M.1
Chi, C.2
Ankerst, D.P.3
-
7
-
-
0037812658
-
The influence of finasteride on the development of prostate cancer
-
Thompson, I. M., Goodman, P. J.Tangen, C. M. 2003. The influence of finasteride on the development of prostate cancer. New England Journal of Medicine, 349: 215-224.
-
(2003)
New England Journal of Medicine
, vol.349
, pp. 215-224
-
-
Thompson, I.M.1
Goodman, P.J.2
Tangen, C.M.3
-
8
-
-
34147183350
-
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection
-
Thompson, I. M., Tangen, C. M.Goodman, P. J. 2007. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection. Journal of Urology, 177: 1749-1752.
-
(2007)
Journal of Urology
, vol.177
, pp. 1749-1752
-
-
Thompson, I.M.1
Tangen, C.M.2
Goodman, P.J.3
|